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Abstract
Acute ocular hypertension (AOH) is a condition found in acute glaucoma. The purpose of this study is to investigate the
protective effect of Lycium barbarum polysaccharides (LBP) and its protective mechanisms in the AOH insult. LBP has been
shown to exhibit neuroprotective effect in the chronic ocular hypertension (COH) experiments. AOH mouse model was
induced in unilateral eye for one hour by introducing 90 mmHg ocular pressure. The animal was fed with LBP solution
(1 mg/kg) or vehicle daily from 7 days before the AOH insult till sacrifice at either day 4 or day 7 post insult. The
neuroprotective effects of LBP on retinal ganglion cells (RGCs) and blood-retinal-barrier (BRB) were evaluated. In control
AOH retina, loss of RGCs, thinning of IRL thickness, increased IgG leakage, broken tight junctions, and decreased density of
retinal blood vessels were observed. However, in LBP-treated AOH retina, there was less loss of RGCs with thinning of IRL
thickness, IgG leakage, more continued structure of tight junctions associated with higher level of occludin protein and the
recovery of the blood vessel density when compared with vehicle-treated AOH retina. Moreover, we found that LBP
provides neuroprotection by down-regulating RAGE, ET-1, Ab and AGE in the retina, as well as their related signaling
pathways, which was related to inhibiting vascular damages and the neuronal degeneration in AOH insults. The present
study suggests that LBP could prevent damage to RGCs from AOH-induced ischemic injury; furthermore, through its effects
on blood vessel protection, LBP would also be a potential treatment for vascular-related retinopathy.
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Introduction
Glaucoma, the leading cause of vision loss in the world [1], is
associated with the loss of retinal ganglion cells (RGCs) and their
axons [2]. Although the elevation of intraocular pressure (IOP)
plays a key role in the mechanism of glaucoma, other factors
including ischemia [3] are also involved in the pathogenesis. The
acute ocular hypertension (AOH) is a well-established animal
model for producing retinal degeneration, which has been used to
investigate the pathogenesis of RGC death and possible thera-
peutic interventions for neuroprotection [4,5,6].
Previous studies suggest that neurodegeneration in glaucoma
undergoes two phases: the direct damage to RGC and axons and
the secondary damage by responses of non-neuronal cells. The
secondary damage is considered to be the major cause of RGC loss
in glaucoma [7,8]. The breakdown of blood-brain-barrier (BBB)
and blood-retinal-barrier (BRB) has been reported in transient
middle cerebral artery occlusion (MCAO)-induced ischemic injury
in the brain and retina [9,10,11,12]. However, long-term effects of
disrupted BRB on retinal ganglion cells and blood vessels have not
been reported in AOH retinal injury.
Endothelin-1 (ET-1), synthesized in vascular endothelial cells, is
a potent vasoconstrictor. Over-expression of ET-1 could induce
BBB damage by down-regulating the level of occludin, the key
protein to construct tight junction between blood vessel endothe-
lial cells [10]. RAGE, the receptor for advanced glycation end-
products (AGEs), can recognize multiple ligands such as amyloid-b
and AGEs. Over-expressed RAGE on blood vessel endothelial
cells can activate the membrane-transporting system of AGE-
RAGE and Ab, resulting in accumulation of AGEs and Ab in
parenchyma and release of ET-1, which is reported in diabetic
microangiopathy and Alzheimer’s disease (AD) [13,14,15]. How-
ever, their roles in AOH retinal injury still do not define.
Lycium barbarum, known as Fructus Lycii or Wolfberry in the
West, is a kind of traditional Chinese medicine (TCM) for a very
long period of time with anti-aging effects. Interestingly, potential
neuroprotective effects of Lycium barbarum polysaccharides (LBP) on
neurons in the CNS has recently been discovered in many
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previous studies by different groups [16,17,18,19,20,21,22]. Our
previous studies have shown the neuroprotective effects of LBP on
RGCs in both a chronic ocular hypertension model of glaucoma
[23,24,25] and in MCAO-induced ischemic retina [11]. In
addition, the protective effects of LBP against Ab neurotoxicity
on neurons in Alzheimer’s disease have also been observed
recently [18,19,20]. In the present study, we want to explore the
protective effects of LBP on retinal ganglion cells, blood-retinal-
barrier (BRB) and blood vessels in AOH models.
Methods
Animals
C57BL/6N male mice (10 to 12 weeks, weight around 20–25 g)
were used in this study. They were maintained on a 12 hour light-
dark cycle and received food and water ad libitum. All experimental
designs and protocols were conducted according to the institu-
tional guidelines for the care and use of laboratory animals at The
University of Hong Kong, and were approved by the Committee
for the Use of Live Animals in Teaching and Research
(CULTRA#1664-08) at The University of Hong Kong.
Animal model of acute ocular hypertension (AOH)
The animals were anesthetized with a mixture of ketamine
(80 mg/kg) and xylazine (8 mg/kg). One drop of proparacaine
hydrochloride 0.5% (Alcaine; Alcon, Ltd., Fort Worth, TX)
followed by a drop of mydriacyl (Alcon, Ltd., Fort Worth, TX) was
applied to the eyes for desensitizing the cornea and mydriasis.
AOH was induced by inserting a micro-glass needle into the
anterior chamber of the right eye. The needle was linked with a
reservoir of balance salt solution (BSS, Alcon, Ltd., Fort Worth,
TX) to keep the IOP at 90 mmHg for 60 minutes. The state of
AOH was verified by checking the whitening of the anterior
segment of the globe and blanching of episcleral veins under the
surgical microscopy. During the surgical procedure, animal’s
temperature was kept at 3760.5uC with a heating pad. After the
procedure, 0.3% tobramycin ointment (Alcon, Fort Worth, TX)
was applied to the conjunctival sac.
Drug administration
The preparation for Lycium barbarum polysaccharides (LBP)
extracts was the same as reported previously [18]. Here, a pre-
treatment procedure was used [11,23,24]. The freeze-dried
powder of LBP was freshly diluted with phosphate-buffered saline
(PBS; 0.01 M; pH 7.4). Experimental animals were divided into
two groups: orally feed with either LBP solution or PBS as vehicle-
treated control (n = 7 per group). Drug administration was
performed using a feeding needle with LBP of 1 mg/kg or vehicle
daily from 7 days before the insult till sacrifice.
Sample processing
Animals were sacrificed with an overdose of sodium pentobar-
bital. Eyeballs were removed and fixed in 4% paraformaldehyde
(PFA) overnight at 4uC. Using a suture to clarify the orientation of
each eyeball, samples were dehydrated with a graded series of
ethanol and xylene and subsequently embedded in paraffin wax.
Cross-sections of 7 mm thick were cut. For some animals, retinal
flat-mounts were prepared after removing the eye ball. The flat-
mounts were fixed in 4% PFA for 2–4 hours.
Immunohistochemistry
Samples were rinsed with PBS, and blocked in PBS with 0.3%
Triton X-100 and 10% goat serum for 1 hour. Then, they were
incubated with primary antibodies overnight at 4uC, followed by
secondary antibodies (Table 1). For cross-sections, fluorescence
secondary antibody was incubated for 2 hour at room tempera-
ture, or biotinylated secondary antibody was incubated for 1 hour
and then conjugated with avidin-biotin-peroxidase-complex (ABC)
kit and detected using Diaminobenzidine tetrahydrochloride
(DAB). For flat-mounted retinas, secondary antibody was incu-
bated overnight at 4uC. Diamidino-2-phenylindole (DAPI) 0.2%
was used in some staining procedures to visualize the nuclear.
Retinal whole mounts were then mounted on slides and visualized
using a fluorescent microscope (Zeiss, Oberkochen, Germany) or
confocal laser scanning microscope LSM 510 Meta (Zeiss,
Oberkochen, Germany).
IgG extravasations
IgG leakage can be used to detect the damage of the BRB,
which has been reported in previous studis [11,26]. Retinal
sections were prepared as described above and blocked with 10%
normal goat serum for 1 hour. Then they were incubated with
Mouse-On-Mouse biotinated anti-mouse IgG secondary antibody
and avidin-biotin-peroxidase-complex (ABC). The positive immu-
noreactivity of IgG was detected with DAB.
Histological evaluations
On flat-mounted retinas, RGCs were labeled and counted using
b-tubulin III staining [27,28]. The counting method has been
described previously [29,30]. Briefly, under an eye-piece grid of
2006200 mm2 along the median line of each quadrant, six
microscopic fields for each quadrant with a total of 24 areas per
retina were counted starting from the optic disc to the border at
400 mm intervals, corresponding to approximately 3% of each
retina. The data were shown as percentage loss of RGCs.
On retinal cross-sections, several histological evaluations were
performed. Hematoxylin and Eosin (H&E) staining was done to
visualize the inner retinal layer (IRL), which ranges from the inner
limiting membrane (ILM) to the inner nuclear layer (INL). We
chose to measure the thickness of IRL because previous studies
have reported that the main alteration of retina after AOH is
formed in the IRL [31] [32]. Our pilot study also did not find any
significant change in the outer nuclear layer (ONL). For
consistency, the sections containing optic nerve stump were used,
and at least three discontinuous sections (per animal) were
analyzed. Image at 4006 magnification of the middle retina at
1.1 mm on both sides from the optic nerve head [33] were
analyzed using StereoInvestigatorH software (MBF Bioscience-
MicroBrightField Inc).
For other evaluations (IgG, PECAM-1, a-SMA), at least 10
discontinuous sections (per animal) were randomly chosen to
perform fluorescence staining. Quantitative method was used as
reported previously [26,34] [35]. The modification in the present
study was that the staining signals were calculated by per
millimeter (mm), but not using per square pixel, since the thickness
of retinas has been significantly changed in AOH model [31,32],
however the retinal length is constant theoretically. IgG was used
to represent the blood vessel density as described by our previous
studies [26]. Each dot or tube was counted as one signal of blood
vessels. Blood vessel density was estimated by counting all signals
in the ganglion cell layer (GCL) and inner nuclear layer (INL)
versus the whole length of the retina. PECAM-1 labeled
endothelial cells and a-SMA labeled pericytes in capillaries were
also counted as described above.
Western blotting
The level of occludin and RAGE in the retina was measured
using Western blotting. The retinas were homogenized in lysis
LBP Protected RGCs and Retinal Vasculature
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buffer (10 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 10% protease inhibitor cocktail and 1% phosphatase
inhibitor cocktails) and centrifuged (2000 g, 5 min, 4uC). The
supernatant was measured by protein assay kit (Bio-Rad Labora-
tories, US). A 40 mg aliquot of proteins from each individual
animal was subjected to 12.5% SDS-polyacrylamide gel electro-
phoresis and transferred into PVDF membrane. The blot was
incubated with antibody against occludin (1:1000, Invitrogen),
RAGE (1:1000, R&D) and b-actin (1:10000, Santa Cruz). The
secondary antibody was Horseradish Peroxidase-conjugated sec-
ondary antibody (Dako, Japan). Signals were visualized with ECL
(Amersham, Buckinghamshire, UK) and quantitated using Image
J software. The ratio of the expression of occludin and RAGE was
determined after normalizing the individual b-actin levels.
Statistics
Retinas of the contralateral eyes from the PBS-fed-AOH and
LBP-fed-AOH groups formed the non-AOH control group. The
PBS-fed-AOH group was compared with non-AOH control
group. The LBP-fed-AOH group was compared with PBS-fed-
AOH and non-AOH control groups. Each analysis was performed
in a blinded manner to eliminate any subjective bias, where the
slides were analyzed by observers-blinded to the identification of
the mice. Data were presented as mean6 standard deviation (SD).
One-way analysis-of-variance (ANOVA) followed by Bonferroni’s
post test was used for the counting data analysis. Kruskal-Wallis
Test followed by the Dunn’s multiple comparison tests was used
for semi-quantitative analysis of ICC staining intensity using
GraphPad Prism software (San Diego, CA, USA). Statistically
significant difference was set at P,0.05.
Results
LBP protected retina from neuronal loss in AOH model
AOH procedure induced an obvious loss of RGCs and thinning
of IRL as reported by the previous studies [31,32]. To detect the
effects of LBP, we estimated the number of RGCs at day 4 post the
AOH insult and the IRL thickness at day 7 after the operation
when the acute damage became stable in the retinal tissue. At day
4 post-operation, the loss of RGCs in the PBS-fed-AOH group was
severe (3362.4%) with remaining RGC number at 2654698.1/
mm2 (Figure 1B) when compared with the non-AOH control
retina (39626151.3/mm2) (Figure 1A) (P,0.001). Compared with
the PBS group, the number of remaining RGCs was higher in the
LBP-fed-AOH group (3328691.6/mm2) (Figure 1C) (P,0.01);
however, there was still a significant loss of RGCs in the LBP-fed-
AOH group (1562.3%) when compared with the non-AOH
control retina (P,0.05) (Figure 1D, 1E).
At day 7 post-operation, the IRL was thinnest (5065.2 mm) in
the PBS-fed-AOH group (Figure 2B); it was also thinner in the
LBP-fed-AOH group (8764.9 mm) (Figure 2C) when compared
with the non-AOH control retina (9863.6 mm) (Figure 2A).
Statistical analyses showed significant differences among the three
groups (Figure 2D).
LBP protected the stability of retinal vasculature
To detect the effects of LBP on the protection of BRB, IgG
extravasation was examined using the DAB method on retinal
sections. Using this method, the IgG leakage appeared as diffuse
and fuzzy non-shaping brown signals distributed in the tissue
outside the leaky blood vessels as described in many previous
studies [9,10,26]. Here, when compared with the non-AOH
control (Figure 3A), the IgG staining appeared as dark-brown non-
shaping signals outside the leaked blood vessels diffusing in the
retinal parenchyma in the PBS-fed-AOH retina (Figure 3B).
However, it was difficult to identify which blood vessel contributed
to the leakage so we did not count the numbers of leaky blood
vessels. In the LBP-fed-AOH group (Figure 3C), the IgG staining
in retinal parenchyma appeared lighter than the PBS group, but
was also presented as weak fuzzy brown signals around the blood
vessels when compared with the non-AOH control (Figure 3A).
Table 1. Antibody list.
Antibody Dilution Host Company Cat. Number
b-tubulin III 1:500 Mouse Covance MMS-435P
GFAP 1:400 Mouse Sigma G3893
GS 1:600 Mouse Millipore MAB302
PECAM-1 1:400 Rat BD Pharmingen 553370
a-SMA 1:200 Mouse Sigma A2547
NG2 1:200 Rabbit Millipore AB5320
Occludin 1:1000 Rabbit Invitrogen 40-4700
ET-1 1:1600 Rabbit Peninsula T-4050
RAGE 1:200 Rabbit Abcam ab3611
Ab1–42 1:50 Rabbit Abcam ab10148
AGE 1:200 Rabbit Genetex GTX43720
Alexa Fluor 568 (Goat anti-rabbit) 1:200 Molecular Probes A11036
Alexa Fluor 488 (Goat anti-mouse) 1:200 Molecular Probes A11029
Alexa Fluor 568 (Goat anti-rat) 1:200 Molecular Probes A11077
DAPI 1:5000 Sigma D9564
DAB kit Invitrogen 002114
MOM kit Vector Lab FMK-2201
doi:10.1371/journal.pone.0045469.t001
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Using occludin staining, we verified that the change in tight
junction integrity between blood vessel endothelial cells might be
one of the causes for the IgG leakage from the blood vessels in the
AOH model. On retinal flat-mounts, in the network of capillaries
in the non-AOH control (Figure 4A), the tight junctions appeared
as chains along the capillaries; however, in the PBS-fed-AOH
group (Figure 4B), broken tight junctions were observed every-
where in capillaries. On the contrary, in the LBP-fed-AOH group
(Figure 4C), the tight junctions were shown as un-broken chains
along the capillaries similar to the non-AOH control. Western
blotting data confirmed the decreased level of occludin in the PBS-
fed-AOH group when compared with the non-AOH control and
the increased level in the LBP-fed-AOH group when compared
with the PBS-fed-AOH group (Figure 4D).
Using PECAM-1 to label blood vessel endothelial cells, the
profile of retinal vasculature was shown on flat-mounts. Compared
with the non-AOH control (Figure 5A, 5D), the density of retinal
blood vessels in the PBS-fed-AOH group was reduced (Figure 5B,
5E). However, the density of retinal vessels in the LBP-fed-AOH
group (Figure 5C, 5F) was similar to that in the non-AOH control
retina. Also, on flat-mounted retinas, the density of NG2 labeled
pericytes in the PBS-fed-AOH group was reduced (Figure 5H)
when compared with the non-AOH control (Figure 5G). However,
in the LBP-fed-AOH group (Figure 5I), the density was similar to
the non-AOH control retina.
To further quantify the change in blood vessels in the AOH
retina, IgG immunostaining was used to evaluate the density of
retinal blood vessels, PECAM-1 immunostaining was used to
evaluate the density of endothelial cells and a-SMA immuno-
staining was used to evaluate the density of pericytes of blood
vessels on retinal cross-sections. Since IgG immunostaining could
be clearly detected inside the lumen of blood vessels, counting the
labeled blood vessels indicated the number of blood vessels. This is
different from the IgG extravasations described above which
focused on signals outside the lumen of the blood vessels.
Compared with the non-AOH control retina (Figure 6A), the
density of IgG-labeled blood vessels in the GCL and INL of the
PBS-fed-AOH group was severely reduced (Figure 6B). Interest-
ingly, in the LBP-fed-AOH group (Figure 6C), more IgG-labeled
blood vessels were observed than the PBS-fed-AOH group, and
this was comparable to the non-AOH control. Quantification
supported these changes with statistical significance (Figure 6J).
PECAM-1 stained signals showing the density of blood vessel
endothelial cells was decreased in the PBS-fed-AOH group
(Figure 6E) when compared with the non-AOH control
(Figure 6D), but it was higher in the LBP-fed-AOH group
(Figure 6F) than the PBS-fed-AOH group, which was comparable
to the density of the non-AOH control. Quantification supported
these changes with statistical significance (Figure 6K). These data
suggested that LBP treatment protected the endothelial cells of
blood vessels against AOH.
Figure 1. Protection of RGCs in LBP-fed-AOH retina at day 4 after AOH. (A–C) Representative photos of b-tubulin-III labeled RGCs on retinal
flatmounts from mid-peripheral area, in the non-AOH control group (A), PBS-fed-AOH group (B) and LBP-fed-AOH group (C). (D) Quantification of no.
of cells/mm2. (E) Quantification of the percentage of loss of RGCs. * P,0.05,# P,0.01, ** P,0.001. Scale bar: 20 mm. RGCs, retinal ganglion cells; PBS,
phosphate-buffered saline vehicle; AOH, acute ocular hypertension; LBP, Lycium Barbarum Polysaccharides solution.
doi:10.1371/journal.pone.0045469.g001
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Immunoreactivity of a-SMA staining also showed this trend of
change (Figure 6G versus 6H and 6I) and quantification supported
it with statistical significance (Figure 6M), which suggested that
LBP treatment also protected the pericytes of blood vessels against
the insult of AOH.
LBP down-regulated the expression of ET-1
Endothelin-1 (ET-1) can contribute to the damage of BBB in
ischemic brain as reported previously [9,10]. In the present study,
the expression of ET-1 was shown as a background staining in the
non-AOH control retina with some locally strong staining signals
in the GCL (Figure 7A–7D). These ET-1 positive signals
(Figure 7C) belonged to astrocytes (Figure 7B) since they co-
labeled with GFAP (Figure 7D). In the PBS-fed-AOH group, the
expression of ET-1 was up-regulated in the GCL, IPL, INL and
OPL (Figure 7E). In the LBP-fed-AOH group (Figure 7F), the
expression of ET-1 was down-regulated when compared with the
PBS-fed-AOH group; however, there were still stronger ET-1
positive signals in the GCL when compared with the non-AOH
control retina, which should belong to the proliferated astrocytes
as described above.
LBP down-regulated the expression of RAGE
RAGE was detected in the clinical patients of glaucoma [36]. It
was reported that one role of RAGE was to transport Ab across
the BBB to the brain tissue in Alzheimer’s disease [13]. In the
present study, a mild positive staining of RAGE in the neurons of
the GCL and INL was observed in the non-AOH control retina
(Figure 8A). In the PBS-fed-AOH group, the expression of RAGE
was up-regulated; the strong positive signals were found in the
neurons of the GCL and INL (Figure 8B). Co-labeled with
PECAM-1, the positive signals of RAGE were also observed in
endothelial cells (Figure 8D). The positive signals of RAGE were
co-labeled with Glutamine synthetase (GS) and found in the end-
feet, processes and the cell bodies of Mu¨ller cells (Figure 8E).
Astrocytes in the GCL labeled with GFAP could also express
RAGE (Figure 8F). In the LBP-fed-AOH group, the expression of
RAGE was down-regulated when compared with the PBS-fed-
AOH group showing no positive signal in the blood vessel
endothelial cells; however, there were still positive signals in the
neurons of the GCL and INL (Figure 8C). Western blotting data
confirmed the increased level of RAGE in the PBS-fed-AOH
retinas when compared with the non-AOH control and the
decreased level in the LBP-fed-AOH retinas when compared with
the PBS-fed-AOH group (Figure 8G).
LBP down-regulated the expression of Ab1–42
The expression of Ab1–42 was detected in the chronic ocular
hypertension rats and in DBA/2J glaucoma mice [37,38]. In the
present study, the non-AOH control retina did not express Ab1–42
(Figure 9A, 9D); however, in the PBS-fed-AOH group, staining of
Ab1–42 were detected in: 1) the neurons in the GCL, 2) the INL
but the signal was patchy (Figure 9B), and 3) the lumen of blood
vessels (Figure 9E), suggesting the presence of the vascular source
of Ab1–42 deposition in AOH. However, in the LBP-fed-AOH
group, the positive staining signal of Ab1–42 was rarely detected
(Figure 9C, 9F).
LBP down-regulated the expression of AGE
Since AGE is a key ligand of RAGE and was also detected in
glaucomatous retina from patients, we also used it to examine the
effect of LBP on AOH retina. In the non-AOH control retina, the
positive AGE immunoreactivity was confined to the blood vessels
(Figure 10A, 10B). In the PBS-fed-AOH group, the strong AGE
immunoreactivity was expressed in the neurons in the GCL and
INL and the processes of Mu¨ller cells in the IPL associated with
their end-feet in the ILM and OLM; even some non-shaped
Figure 2. Protection of inner retinal layer thickness in LBP-fed-
AOH retina at day 7 after AOH. (A–C) Representative photos of HE-
stained retinal sections from the middle area in the non-AOH control
group (A), PBS-fed-AOH group (B) and LBP-fed-AOH group (C). (D)
Quantification of the inner retinal thickness. * P,0.05, # P,0.01,
** P,0.001. Scale bar: 50 mm. HE, Hematoxylin and Eosin staining; PBS,
phosphate-buffered saline vehicle; AOH, acute ocular hypertension;
LBP, Lycium Barbarum Polysaccharides solution; ILM, internal limiting
membrane; INL, inner nuclear layer.
doi:10.1371/journal.pone.0045469.g002
Figure 3. Prevention of BRB leakage in LBP-fed retina at dat 4 after AOH. Representative photos of IgG staining on retinal sections, in the
non-AOH control group (A), PBS-fed-AOH group (B) and LBP-fed-AOH group (C). Scale bar: 25 mm. BRB, blood-retinal-barrier; PBS, phosphate-buffered
saline vehicle; AOH, acute ocular hypertension; LBP, Lycium Barbarum Polysaccharides solution; GCL, ganglion cell layer; INL, inner nuclear layer.
doi:10.1371/journal.pone.0045469.g003
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diffuse staining signals were detected distributing in the parenchy-
ma of other retinal layers (Figure 10C). In the LBP-fed-AOH
group, the expression of AGE was down-regulated compared with
the PBS-fed-AOH group; the positive immunoreactivity was
mostly confined to the blood vessels. However, there were still
some strong positive signals in the end-feet and processes of Mu¨ller
cells (Figure 10D).
Discussion
In this study, we demonstrated transient elevation of IOP at
90 mmHg for 60 minute induced a marked loss of RGCs and
thinning of inner retinal layers, which are associated with retinal
gliosis and retinal vasculature damage. Interestingly, we found that
feeding LBP 7 days before AOH procedure improved the survival
ratio of RGCs and reduced the thinning of inner retinal layers. In
addition, blood vessel cells were protected and eventually the BRB
damage was prevented after AOH insults.
Combined with the ischemic and mechanical injury, AOH
model shares some similarity with clinical acute glaucoma. It has
thus been commonly used to investigate the degeneration and
neuroprotection for RGCs [31,39] [40]. In the previous studies,
according to their specific investigating designs, the elevation of
IOP and its duration has been regulated correspondingly, which
are different from each other. The common range of IOP is from
80 to 120 mmHg and the duration of AOH is from 45 to 120 min
[41] [31]. One previous study of electroretinography (ERG) has
reported that nonspecific functional changes will be produced
when AOH is above 50 mmHg in Brown-Norway rats. Thus, level
below 50 mmHg belongs to experimental glaucoma model [42].
However, another study reports under the condition of 80–
90 mmHg with the duration of AOH 120 min to Lewis rats and
90 min to C57BL/6J mice could produce the similar capillary
degeneration like diabetes [41]. Taken together, from the view of
vasculature, the elevation of IOP and extension of its duration
could induce damage to blood vessels to initiate the mechanism of
ischemia reperfusion (I/R) injury. Clinical studies have shown that
Figure 4. Protection of tight junctions between endothelial cells in LBP-fed retina at day 4 after AOH. (A–C) Representative photos of
occludin-stained tight junctions in the network of capillaries on retinal flat-mounts, in the non-AOH control group, PBS-fed-AOH group and LBP-fed-
AOH group. Note that the broken chains of tight junctions in (B). Scale bar: 15 mm. PBS, phosphate-buffered saline vehicle; AOH, acute ocular
hypertension; LBP, Lycium Barbarum Polysaccharides solution.
doi:10.1371/journal.pone.0045469.g004
Figure 5. Alteration of retinal vasculature at day 4 after AOH
treated with PBS and LBP. (A–C) Representative photos of the
profile of PECAM-1-labeled retinal vasculature on retinal flatmounts, in
the non-AOH control group, PBS-fed-AOH group and LBP-fed-AOH
group. (D–F) The enlarged photos of white boxes in (A–C). (G–I)
Representative photos of NG2-labeled pericytes in retinal vasculature
on retinal flatmounts, in the non-AOH control group (G), PBS-fed-AOH
group (H) and LBP-fed-AOH group (I). Scale bars: 200 mm in A–C and G–
I; 50 mm in D–F. PECAM-1, Platelet endothelial cell adhesion molecule 1;
NG2, neuron-glial antigen 2; PBS, phosphate-buffered saline vehicle;
AOH, acute ocular hypertension; LBP, Lycium Barbarum Polysaccharides
solution.
doi:10.1371/journal.pone.0045469.g005
LBP Protected RGCs and Retinal Vasculature
PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e45469
transient elevation of IOP higher than 30 mmHg during acute
episode of glaucoma could induce I/R injury in human
[43,44,45]. Thus, in AOH animals, it might involve two critical
mechanisms of ischemic and mechanical injury under the above
range of experimental ocular hypertension.
Previous study has reported the loss of capillaries in the AOH
model using the method of retinal vasculature isolation [41]. Here,
we verified this result by counting the IgG stained blood vessels.
Although using the methods in this study, we could not observe
directly the degenerated capillaries, being represented as a cellular
capillaries lacking perfusion [34,35,41]. Our data could show the
reduction of retinal vasculature in the PBS-fed-AOH group and
the increase in the LBP-fed-AOH group. Although we did not
observe and compare the nonvascular cells in the AOH retina
between the PBS fed group and LBP fed group, which was present
under ischemic conditions as reported in other models [34,35,41],
our data showed the protective effect of LBP to increase the
survival of retinal endothelial cells and pericytes from the AOH
injury. Moreover, since pericytes could have provided vascular
stability and controlled endothelial proliferation [35], it is
reasonable to believe that LBP protected pericytes. Therefore,
LBP was effective in resisting endothelial proliferation and keeping
the stability of their numbers in ischemia. The interesting findings
from our study were to show protective effects of LBP on retinal
blood vessels. As retinal ischemia is a common pathology in many
eye diseases such as glaucoma, diabetic retinopathy and other
vascular diseases of retina, our data suggests that LBP might be a
potential useful drug for treating these similar diseases.
Figure 6. Attenuation of the density of retinal blood vessels after AOH treated with PBS and protection by the treatment of LBP.
Representative photos of the IgG-labeled retinal blood vessels on retinal sections, in the non-AOH control group (A), PBS-fed-AOH group (B) and LBP-
fed-AOH group (C) at day 7. Representative photos of the PECAM-1-labeled endothelial cells on retinal sections, in the non-AOH control group (D),
PBS-fed-AOH group (E) and LBP-fed-AOH group (F) at day 7. Representative photos of the a-SMA-labeled pericytes on retinal sections, in the non-
AOH control group (G), PBS-fed-AOH group (H) and LBP-fed-AOH group (I) at day 7. Quantification of the time course change (day 4 and day 7) of
blood vessel density (J), endothelial cell numbers (K) and pericyte numbers (M). *P,0.05 compared with non-AOH; # P,0.05 compared with
PBS+AOH. Scale bar: 50 mm. IgG, Immunoglobulin G; PECAM-1, Platelet endothelial cell adhesion molecule 1; a-SMA, a-smooth muscle actin; PBS,
phosphate-buffered saline vehicle; AOH, acute ocular hypertension; LBP, Lycium Barbarum Polysaccharides solution; GCL, ganglion cell layer; INL, inner
nuclear layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0045469.g006
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BRB disruption has been reported in other ischemic models
[9,46]. Here, we found that it was also severely damaged in AOH
retinas, and LBP treatment maintained the integrality of BRB,
which is consistent with our previous study of MCAO retina
recently [11]. Thus, the protective effect of LBP on BRB in AOH
retinas may be related to the survival of blood vessel endothelial
cells and pericytes associated with the integrality of tight junction
between endothelial cells. The expression level of occludin has
been reported to decrease in ischemia [9,10]. Moreover, our
previous study also has shown that over-expression of ET-1 in
astrocytes (GET-1 mice) and in blood vessel endothelial cells
(TET-1 mice) could contribute to the damage of blood-brain-
barrier (BBB) by down-regulating the level of occludin in the brain
of MCAO [9,10]. Here, we demonstrated the up-regulation of
ET-1 in AOH retinas, and down-regulation after LBP treatment.
Thus, the effect of LBP on down-regulating the expression of ET-1
in AOH retinas could be another mechanism for its protective
effects on BRB damage.
The significance of BBB damage is extravasation of plasma
protein from the circulation, which can trigger inflammation,
oxidative stress, perivascular edema, and axonal demyelination
[47]. Moreover, alterations in BBB could facilitate some cross-
membrane transportation for circulating toxins [48,49]. Assuming
this is also true for BRB, the extensive distribution of IgG
extravasations in the present study suggested the presence of toxic
factors effusing from the disrupted BRB into the AOH retina.
Thus, in the AOH retina, the disruption of BRB may be served as
a basis for the involvement of damaging factors in the molecular
mechanisms of retinal degeneration. Subsequently, protection to
BRB damage should be a key target for neuroprotection related to
ischemia.
The present study demonstrated the expression and distribution
patterns of the receptor for advanced glycation end products
(RAGE) in the AOH retina. Associated with the alternation of
BRB, vascular RAGE could serve as a cross-membrane trans-
porter for the deposition of Ab in tissue. Here, we also detected
Ab1–42 immunoreactivity in blood vessels and neurons in the AOH
retina. Such molecular mechanism has already been demonstrated
in an experimental AD animal model [13]. The direct effect of this
transportation is the increasing release of ET-1 from endothelial
cells, which could in turn contract the blood vessels to promote
ischemia [13]. It also may be a cause of the up-regulation of ET-1
detected in the AOH retina.
Previous study has reported the accumulation of advanced
glycation end products (AGEs) in ischemic brain [50]. Our present
data confirmed that AGE was up-regulated in the AOH retina by
immunohistochemical staining. Furthermore, we also detected the
alteration of the distribution of AGEs after AOH from blood
circulation to the AOH retina. We believe that it may be related to
the up-regulation of vascular RAGE. The transportation of AGEs
by vascular RAGE could be mediated by similar mechanism for
the transportation of circulating Ab [13]. One of such negative
effects is to initiate the reactivation of AGE-RAGE axis in the
AOH retina [51,52]. One is contributing to the disruption of BRB
[53], as a cause of BRB damage as observed in this study. Other
negative effects include inducing pro-inflammatory, pro-adhesive
and growth-stimulating signals [54]. Moreover, previous study has
reported the up-regulation of expression of AGE and RAGE in the
retina of glaucoma patients [36], as well as Ab in DBA/2J
glaucoma mice [37]. Taken together the presence of these
biomarkers in the AOH retina observed in our study, it is
suggested that RAGE activity may be responsible for the
Figure 7. Up-regulation of ET-1 in PBS-fed retina and down-regulation in LBP-fed retina at day 4 after AOH. (A) The expression of ET-1
in the non-AOH retina. (B–D) Co-localization of ET-1 in astrocytes in GCL (yellow color) in (B) merged by the staining of ET-1 (red color) of (C) and
GFAP (green color) of (D). (E) The distribution and expression patterns of ET-1 in the PBS-fed-AOH retina. (F) The distribution and expression patterns
of ET-1 in the LBP-fed-AOH retina. Note that the expression of ET-1 in astrocytes (long white arrows) and in the processes of Mu¨ller cells (short white
arrows). Scale bars: 20 mm. ET-1, endothelin-1; GFAP, Glial fibrillary acidic protein; PBS, phosphate-buffered saline vehicle; AOH, acute ocular
hypertension; LBP, Lycium Barbarum Polysaccharides solution; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0045469.g007
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Figure 8. Up-regulation of the expression of RAGE in PBS-fed retina and down-regulation in LBP-fed retina at day 4 after AOH.
Representative photos of RAGE immunostaining on retinal sections in the non-AOH control group (A), PBS-fed-AOH group (B) and LBP-fed-AOH
group (C). The expression of RAGE is present in the processes of Mu¨ller cells (white arrows) in (B), and no RAGE signals are observed in blood vessels
(asterisks) in (A) and (C). (D) The PBS-fed-AOH retina shows the co-localization of RAGE in endothelial cells (yellow arrows) using the marker PECAM-1
(green color) double-staining with RAGE (red color). (E) The PBS-fed-AOH retina shows the co-localization of RAGE is also present in the end-feet,
processes and cell bodies of Mu¨ller cells (bold white arrows) in yellow color using the marker GS (green color) double-staining with RAGE (red color).
(F) The PBS-fed-AOH retina shows the co-localization of RAGE is also present in astrocytes (yellow color) using the marker GFAP (green color) double-
staining with RAGE (red color). (G) Comparison of RAGE level in retinas from the non-AOH group, PBS+AOH group and LBP+AOH group. Scale bars:
20 mm. * P,0.05 compared with non-AOH; # P,0.05 compared with PBS+AOH. RAGE, the receptor for Advanced Glycation Endproducts; PECAM-1,
Platelet endothelial cell adhesion molecule 1; GFAP, Glial fibrillary acidic protein; GS, Glutamine synthetase; PBS, phosphate-buffered saline vehicle;
AOH, acute ocular hypertension; LBP, Lycium Barbarum Polysaccharides solution; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0045469.g008
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accumulation of AGE and Ab, and ischemia might be one of the
initiator of reactivation of RAGE in glaucoma.
LBP could protect cerebral neuron from Ab toxicity as reported
in our previous in vitro studies [18,19,20,21]. Here, we verified its
neuroprotective effect of anti-Ab1–42 in a vivo model of AOH. The
possible molecular mechanism is related to reducing the transpor-
tation of Ab by vascular RAGE from circulation. Furthermore, in
the present study, we also demonstrated that LBP could suppress
the reactivation of AGE-RAGE axis, as known in many ischemic
related retinopathies, which could be interesting in the protective
mechanisms of BRB and retina in diseases.
Conclusions
Our data evaluated the neuroprotective effects of LBP to anti-
ischemic insult induced by AOH. The possible mechanism is
related to down-regulating the expressions of RAGE, ET-1, Ab
and AGE in the retina, as well as the related signaling pathways
leading to inhibiting the vascular damage and the neuronal
degeneration in AOH. The present study suggests LBP could
prevent damage to RGC and retinal neurons from ischemic injury;
therefore, by targeting the mechanism of blood vessel protection,
LBP would also be a potential treatment for vascular-related
retinopathy.
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Figure 9. Up-regulation of the expression of Ab1–42 in PBS-fed retina and down-regulation in LBP-fed retina at day 4 after AOH.
Representative photos of Ab1–42 immunostaining on retinal sections in non-AOH control group (A), PBS-fed-AOH group (B) and LBP-fed-AOH group
(C). Note that the Ab1–42 staining is present in neurons of GCL (arrows) in (B). (D–F) The enlarged blood vessel in GCL from the non-AOH, PBS+AOH
and LBP+AOH group, respectively. Scale bars: 50 mm. Ab1–42, amyloid-beta 1–42; PBS, phosphate-buffered saline vehicle; AOH, acute ocular
hypertension; LBP, Lycium Barbarum Polysaccharides solution; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0045469.g009
Figure 10. Alteration of the expression of AGE in PBS-fed
retina and LBP-fed retina at day 4 after AOH. (A) The DAB staining
shows the distribution of AGE in non-AOH retina. Note that the arrows
showing the positive signals of AGE are located in blood vessels. (B) The
corresponding fluorescence staining of AGE in non-AOH retina. (C) The
expression patterns of AGE in PBS-fed-AOH retina. (D) The expression
patterns of AGE in LBP-fed-AOH retina. Scale bar: 50 mm. AGE,
Advanced Glycation Endproducts; PBS, phosphate-buffered saline
vehicle; AOH, acute ocular hypertension; LBP, Lycium Barbarum
Polysaccharides solution; GCL, ganglion cell layer; INL, inner nuclear
layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0045469.g010
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